🇺🇸 FDA
Patent

US 10808011

Recombinant HIV-1 envelope proteins and their use

granted A61KA61K39/12A61K39/21

Quick answer

US patent 10808011 (Recombinant HIV-1 envelope proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K39/12, A61K39/21